AL
GH icon

Aspiriant LLC’s Guardant Health GH Stock Holding History

Aspiriant LLC’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,098
Closed -$210K – 285
2021
Q4 		$210K Sell
2,098
-187
-8% -$19.3K 0.01% 266
2021
Q3 		$286K Hold
2,285
– – 0.02% 198
2021
Q2 		$284K Hold
2,285
– – 0.02% 203
2021
Q1 		$349K Hold
2,285
– – 0.02% 168
2020
Q4 		$294K Hold
2,285
– – 0.02% 173
2020
Q3 		$255K Buy
+2,285
New +$209K 0.02% 191
2019
Q3 		– Sell
-2,337
Closed -$202K – 219
2019
Q2 		$202K Buy
+2,337
New +$178K 0.02% 221

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Aspiriant LLC's GH Position: Q1 2022 in Review

Aspiriant LLC sold out of Guardant Health (GH) in Q1 2022, closing a stake of 2,098 shares — an estimated $210K sold.

Aspiriant LLC first reported a position in GH in Q2 2019 and held it in 7 quarters. The position peaked at $349K in Q1 2021. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • Aspiriant LLC reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • Aspiriant LLC sold 2,098 Guardant Health shares in Q1 2022, an estimated $210K.
  • Aspiriant LLC first reported a position in Guardant Health in Q2 2019 and held it in 7 quarters.
  • Aspiriant LLC's Guardant Health position peaked at $349K in Q1 2021.
  • 356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Aspiriant LLC's 13F filing for Q1 2022, filed 6 May 2022.